Top Markets
Coin of the day
Skye Bioscience, Inc. Skye Bioscience, Inc.

Skye Bioscience, Inc.

SKYE
Clasificación en acciones #31353
Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on... Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on developing molecules that modulate G-protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. is headquartered in San Diego, California.
Precio por acción
$0.4018
Capitalización bursátil
$14.12M
Cambio (1 día)
-3.20%
Cambio (1 año)
-88.15%
País
US
Comercio Skye Bioscience, Inc. (SKYE)

Categoría

Historial del precio de la acción de Skye Bioscience, Inc. (SKYE)
Precio más alto de cierre: $0.50 el 2026-08-01

Precio más bajo de cierre: $2.50K el 2014-11-01
Historial del precio de la acción de Skye Bioscience, Inc. desde 2014 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) 27.56%
2025 -68.43%
2024 7.82%
2023 -19.28%
2022 -74.81%
2021 58.02%
2020 -81.19%
2019 -44.44%
2018 157.69%
2017 -64.63%
2016 -42.36%
2015 -92.76%
2014 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$532.21 36.51%
US
$1.00K 51.44%
NL
$111.31 -36.83%
AU
$735.86 6.87%
CH
$257.75 13.01%
BE